Diffuse pain, sometimes called widespread or generalized pain, is pain that is not confined to a single joint, muscle, or body region but instead affects multiple areas at once, often both sides of the body and areas above and below the waist. Unlike a sprained ankle or a pulled muscle, which you can point to, diffuse pain feels everywhere and nowhere at the same time. The causes range from conditions like fibromyalgia to autoimmune diseases, hormonal imbalances, and infections, but the underlying thread connecting most of them is a change in how the nervous system processes pain signals.
How Diffuse Pain Differs from Localized Pain
Most pain you encounter in daily life is localized. You stub your toe and the toe hurts. Tissue damage sends a signal through sensory nerves to your spinal cord and brain, and the pain maps neatly onto where the injury occurred. The International Association for the Study of Pain classifies this as nociceptive pain, meaning it arises from actual or threatened damage to body tissue. There are two other recognized categories: neuropathic pain, caused by damage to the nerves themselves, and nociplastic pain, in which pain processing in the nervous system is altered even though there is no clear tissue or nerve damage.1PubMed Central. Toward Validation of Clinical Measures to Discriminate Between Nociceptive, Neuropathic, and Nociplastic Pain: Cluster Analysis of a Cohort With Chronic Musculoskeletal Pain
Diffuse pain often falls into that third category. When someone has fibromyalgia, for example, there is usually no visible inflammation or structural damage that explains the severity or breadth of the pain. The problem is in the volume knob: the nervous system has turned up its sensitivity to pain signals across the board. That does not make the pain imaginary. It means the machinery generating it is in the brain and spinal cord rather than in a single damaged joint or muscle.
Central Sensitization and the Amplified Alarm System
The concept that best explains diffuse pain is central sensitization. Under normal conditions, your spinal cord and brain filter pain signals. A minor bump might register briefly and then be dismissed. In central sensitization, repeated or intense pain input gradually rewires those filters so they amplify signals instead of dampening them. One key feature is enhanced temporal summation: when a mildly painful stimulus is repeated at a steady rate, the pain grows with each repetition instead of staying the same. This phenomenon has been detected across multiple chronic pain conditions and is considered a hallmark of central sensitization.2PubMed Central. Central Sensitization and Pain: Pathophysiologic and Clinical Insights
Your body also has a built-in brake system for pain. Descending pathways from the brainstem, involving serotonin and noradrenaline signaling, normally tamp down incoming pain signals. When this endogenous inhibition breaks down, pain amplification follows. Researchers study this using a test in which two painful stimuli are applied to two distant body areas at the same time; in a healthy system, the second stimulus reduces the pain caused by the first. In people with chronic widespread pain, this dampening effect is weak or absent.2PubMed Central. Central Sensitization and Pain: Pathophysiologic and Clinical Insights That reduced inhibitory capacity is common across many diffuse pain syndromes and may actually be a risk factor for developing chronic pain in the first place. Research has shown that people with low pain-inhibitory efficiency before surgery are more likely to develop chronic postoperative pain.3PubMed. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states
At a cellular level, chronic pain also involves glial cells in the brain and spinal cord. These cells, which normally support neurons, can shift into a reactive state after tissue or nerve injury. Once activated, they release inflammatory molecules that further amplify pain signaling, creating a feedback loop that persists long after the original injury has healed.4PubMed Central. Glial Activation, Neuroinflammation, and Loss of Neuroprotection in Chronic Pain: Cellular Mechanisms and Emerging Therapeutic Strategies
Fibromyalgia as the Prototypical Diffuse Pain Condition
Fibromyalgia is essentially the medical term for chronic widespread musculoskeletal pain when no other cause can be identified.5PubMed Central. Neurobiology of fibromyalgia and chronic widespread pain It is not a single disease so much as a description of what happens when the nervous system’s pain-processing machinery goes wrong in the ways described above. The diagnosis is clinical, meaning it is based on what you report and what a physical exam reveals, not on blood tests or imaging. Several sets of diagnostic criteria have been developed; the 2016 American College of Rheumatology criteria, which evaluate the distribution of pain and accompanying symptoms like fatigue, sleep problems, and cognitive difficulty, currently show the best performance.6PubMed Central. Disentangling Diagnosis and Management of Fibromyalgia
Brain imaging studies have found that people with chronic widespread pain show altered connectivity in regions associated with the default mode network and the salience network. Compared with healthy controls, patients show decreased connectivity in the posterior cingulate cortex and increased connectivity in the anterior insula, a region heavily involved in processing the emotional dimension of pain.7PubMed Central. The Role of the Insula in Chronic Pain and Associated Structural Changes: An Integrative Review These are not findings that clinicians use for diagnosis, but they reinforce the point that diffuse pain is rooted in real neurological changes, not in a person’s attitude or imagination.
Other Conditions That Cause Diffuse Pain
While fibromyalgia gets most of the attention, widespread pain has a long list of potential causes. The difference matters because some of them are treatable with targeted therapies once identified.
Inflammatory and Autoimmune Conditions
Polymyalgia rheumatica is the most common inflammatory rheumatic disease in people over 50 and is two to three times more common in women. It causes pain and morning stiffness centered on the shoulders and pelvic girdle, and onset can be sudden or build over days to weeks.8PubMed Central. An update on polymyalgia rheumatica Unlike fibromyalgia, it involves measurable inflammation in blood tests and responds well to corticosteroids, so getting the right diagnosis makes a practical difference. Rheumatoid arthritis, lupus, and other systemic autoimmune diseases can also produce diffuse aching, though they tend to involve specific joint swelling that distinguishes them from the more vague, all-over pain of fibromyalgia.
Connective Tissue Disorders
Chronic widespread pain is a common complaint among people with joint hypermobility and Ehlers-Danlos syndrome, particularly the hypermobile type. Pain in these conditions often starts in a few joints and muscles and has a migratory pattern, moving from one area to another over time. Eventually it can become persistent and generalized.9PubMed Central. Pain in Ehlers–Danlos Syndrome: A Non-Diagnostic Disabling Symptom? Several mechanisms converge in these patients: direct tissue damage from unstable joints, impaired proprioception, muscle weakness, and central sensitization.10Clinical and Experimental Rheumatology. Hypermobility, the Ehlers-Danlos syndromes and chronic pain This overlap with fibromyalgia is why some people with hypermobility are told they simply have fibromyalgia when their pain actually has a structural component that benefits from different management strategies like physical therapy focused on joint stability.
Metabolic and Endocrine Causes
Underactive thyroid function is an often-missed cause of widespread muscle pain. Hypothyroid myopathy involves muscle disease with elevated creatine kinase and pain that can feel diffuse and hard to localize.11International Journal of Diabetes & Metabolic Disorders. Hypothyroid Myopathy: A Commonly Missed Complication of Hypothyroidism Because the symptoms overlap so heavily with fibromyalgia, a simple thyroid function blood test should be part of the workup for anyone presenting with unexplained widespread pain. Vitamin D deficiency and diabetes-related nerve damage are other metabolic contributors that deserve screening.
Small-Fiber Neuropathy
Small-fiber neuropathy damages the tiny nerve endings in the skin and organs, producing burning pain, shooting pain, and heightened sensitivity to touch. It can stem from diabetes, autoimmune conditions, or unknown causes. While it often starts in the feet and hands, it can produce more diffuse symptoms that mimic fibromyalgia. Diagnosis relies on clinical history and physical exam, sometimes confirmed by skin biopsy showing reduced nerve-fiber density.12PubMed Central. Diagnosis and treatment of pain in small-fiber neuropathy This distinction is clinically important because some cases of small-fiber neuropathy have a treatable underlying cause, such as an autoimmune antibody that responds to immunotherapy.
Post-Infectious Diffuse Pain
Infections can trigger widespread pain that persists long after the infection itself resolves. This gained enormous visibility during the COVID-19 pandemic. A systematic review found that joint pain and new-onset rheumatic conditions are frequently reported after COVID-19, with various patterns including fibromyalgia-like presentations. Strikingly, between roughly a third and 40% of post-COVID patients in some studies met the classification criteria for fibromyalgia.13PubMed Central. Post-Acute COVID-19 Joint Pain and New Onset of Rheumatic Musculoskeletal Diseases: A Systematic Review
Research into why this happens is still evolving. One study found that antibodies (IgG) from patients with long COVID selectively bind to and activate mast cells, a type of immune cell, at significantly higher rates than antibodies from healthy people. When those antibodies were transferred to mice, the animals showed increased cold sensitivity and decreased activity, mimicking chronic pain behavior.14Journal of Clinical and Translational Science. IgG-mediated mast cell dysregulation drives chronic pain in post-acute sequelae of SARS-CoV-2 (PASC) This kind of immune-mediated mechanism could explain why certain infections leave behind a legacy of pain that looks and feels like fibromyalgia even though it started with a virus. COVID is not unique in this regard; other infections, including Epstein-Barr virus and Lyme disease, have long been associated with post-infectious fatigue and pain syndromes.
The Stress-Pain Connection
People with diffuse pain frequently report that stress makes their symptoms worse, and the physiology backs this up. A systematic review and meta-analysis found that in people with chronic primary pain, higher pain sensitivity was associated with higher blood pressure, higher heart rate, lower heart-rate variability, and higher cortisol levels. These markers reflect dysfunction in both the autonomic nervous system and the stress-hormone axis.15Neuroscience & Biobehavioral Reviews. The stress–pain connection in chronic primary pain: A systematic review and meta-analysis of physiological stress markers in relation to experimental pain responses The relationship appears to run in both directions: chronic stress can heighten pain sensitivity, and chronic pain itself drives a persistent stress response that further amplifies pain. One evolutionary perspective frames this feedback loop as a whole-organism stress response that is deeply conserved across species, suggesting that the tendency toward widespread pain under prolonged stress may be built into our biology rather than being a modern malfunction.16PubMed. An evolutionary stress-response hypothesis for chronic widespread pain (fibromyalgia syndrome)
This does not mean diffuse pain is “caused by stress” in the dismissive sense patients sometimes hear from clinicians. It means the nervous system and the stress-response system share wiring, and when one goes haywire, the other tends to follow. Practical stress-reduction strategies like sleep hygiene, physical activity, and psychological support are not substitutes for medical evaluation. They are complements to it.
The Gut Microbiome and Pain
An emerging area of research links the community of bacteria in the gut to chronic pain processing. The gut microbiome communicates with the brain through immune signaling, nerve pathways, and metabolic products. An imbalanced microbiome, or dysbiosis, can promote systemic inflammation that may worsen pain perception through what is known as the gut-brain axis.17PubMed Central. The Microbiome’s Role in Chronic Pain and Inflammation The gut microbiome could also contribute to central sensitization by influencing microglia and astrocytes, the same glial cells involved in neuroinflammatory pain amplification.18PubMed Central. The Role of the Human Microbiome in the Pathogenesis of Pain
This is still an early-stage field. No one can prescribe a specific probiotic to treat fibromyalgia with any confidence yet. But the connections between gut health and pain processing are strong enough that researchers are actively exploring microbiome-targeted therapies as future options for diffuse pain conditions.
Treatment Approaches for Diffuse Pain
Because diffuse pain typically involves the nervous system’s pain-processing machinery rather than a single damaged structure, treatment strategies tend to be multimodal. There is no single pill that fixes the problem, but several approaches have meaningful evidence behind them.
Medications
Gabapentinoids, a class of drugs including gabapentin and pregabalin, are among the most commonly prescribed medications for chronic widespread pain. In older adults with chronic pain, gabapentinoid use was associated with a larger reduction in pain than opioids, with about 48% of gabapentinoid users reducing their pain-related interference to less-than-daily pain compared to roughly 42% of opioid users. The advantage was dose-dependent, meaning higher gabapentinoid doses showed a larger effect.19PubMed Central. Comparative effectiveness of pain control between opioids and gabapentinoids in older patients with chronic pain Duloxetine and milnacipran, both of which boost serotonin and noradrenaline, are also used specifically for fibromyalgia, targeting the same descending inhibitory pathways whose dysfunction contributes to central sensitization.
Opioids remain controversial for diffuse pain. While they can reduce pain intensity in the short term, the evidence for long-term benefit in conditions like fibromyalgia is weak, and the risks of tolerance, dependence, and hyperalgesia, where opioids paradoxically increase pain sensitivity, make them a poor fit for a condition rooted in overactive pain processing.
Exercise and Cognitive Behavioral Therapy
Exercise and cognitive behavioral therapy each independently improve outcomes for people with chronic widespread pain, and combining them works even better. A randomized trial found that telephone-delivered cognitive behavioral therapy, exercise, and the combination of both all significantly improved outcomes compared to usual care at six and nine months. The combined intervention showed the strongest effect and also improved physical function while reducing passive coping strategies like resting and withdrawing from activity.20PubMed. Cognitive behavior therapy, exercise, or both for treating chronic widespread pain
Exercise can feel counterintuitive when your whole body hurts, but the evidence consistently supports it. A study of fibromyalgia patients found that three weeks of structured exercise therapy led to measurable changes in brain connectivity within regions involved in motor control and the reward system, and those brain changes correlated with improvement in clinical symptoms.21Neurobiology of Pain. Three weeks of exercise therapy altered brain functional connectivity in fibromyalgia inpatients In other words, exercise does not just distract you from pain. It appears to rewire some of the same circuits that central sensitization disrupted.
Genetic and Environmental Roots
Twin studies suggest that chronic widespread pain has both a genetic and an environmental component. Research has identified several candidate genes associated with widespread pain, particularly those in the serotonin-related pathway, which aligns with the role serotonin plays in the descending pain-inhibition system. Unique environmental factors, meaning experiences specific to an individual rather than shared family environment, also contribute to risk.22Journal of Pain Research. Genetic and epigenetic epidemiology of chronic widespread pain This dual influence helps explain why diffuse pain can run in families without following a simple inheritance pattern, and why traumatic events, infections, or sustained stress can trigger it in people who may have been genetically predisposed but previously symptom-free.
Diffuse Pain in Children and Adolescents
Widespread pain is not limited to adults. Juvenile fibromyalgia syndrome is a recognized condition in children and teens, typically diagnosed in adolescence. Like its adult counterpart, it involves chronic diffuse musculoskeletal pain alongside fatigue, sleep disturbance, headaches, and irritable bowel symptoms. No specific lab test confirms it; diagnosis comes from the clinical picture, widespread tenderness on exam, and the exclusion of other conditions.23PubMed Central. The juvenile fibromyalgia syndrome (JFMS): a poorly defined disorder The condition can have a chronic course that significantly affects a young person’s physical function, school attendance, and social development.24PubMed Central. Measures of Juvenile Fibromyalgia
Interestingly, when researchers investigated children and adolescents with unexplained widespread pain, they found that a majority actually had evidence of small-fiber polyneuropathy on objective testing. In one study, definite small-fiber neuropathy was confirmed in 59% of participants, with another 17% classified as probable.25PubMed Central. Evidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndromes The average age of illness onset was around 12, and nearly three-quarters of patients were female. This finding raises the possibility that some children labeled with juvenile fibromyalgia may have a more specific and potentially treatable nerve condition. It underscores the importance of thorough evaluation rather than settling on a diagnosis of exclusion too quickly, especially in a young person whose pain is affecting their ability to function.
When to Seek Medical Evaluation
Not all widespread aching warrants a medical workup. A few days of all-over soreness after a viral illness or an unusually intense week of physical activity is normal and self-limiting. The threshold for concern is persistence and interference with life. If diffuse pain lasts more than three months, disrupts sleep most nights, or limits your ability to work or exercise, it deserves a clinical evaluation. The same is true if widespread pain arrives suddenly in someone over 50, which should prompt evaluation for conditions like polymyalgia rheumatica and other inflammatory diseases. Accompanying symptoms such as unexplained weight loss, fever, or significant morning stiffness lasting more than an hour also warrant prompt attention because they can signal autoimmune or inflammatory processes that respond to specific treatments.
A reasonable initial workup typically includes blood tests for inflammation markers, thyroid function, vitamin D levels, and basic autoimmune screening. If those come back normal and the pattern fits, a clinical diagnosis of fibromyalgia or chronic widespread pain may be appropriate. But the purpose of the testing is to catch the conditions that look like fibromyalgia but aren’t, because some of those have targeted, effective treatments that would be missed if the evaluation stopped too soon.